Kalpataru Multiplier Ltd.

Our Bank & DP Click for Online Payment MF portfolio login smart way to invest in gold
Sovereign gold bond(SGB) Exchange trades funds(ETF)
CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

Company Profile
more from company profile
HomeMarkets Company Profile Smart Quotes

Smart Quotes

JENBURKT PHARMACEUTICALS LTD.

NSE : NABSE : 524731ISIN CODE : INE354A01013Industry : Pharmaceuticals & DrugsHouse : Private
BSE1201.05-12.5 (-1.03 %)
PREV CLOSE () 1213.55
OPEN PRICE () 1203.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 1242
TODAY'S LOW / HIGH ()1197.05 1222.00
52 WK LOW / HIGH () 660.051375
NSE
This Company is not listed in NSE
BSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 1985

Management Info :

Ashish U Bhuta - Chairman Ashish U Bhuta - Managing Director

Registered Office :

Address : Nirmala Apartments,93 Jayprakash Road,Andheri (West),
Mumbai,
Maharashtra-400058

Phone : 022-67603603

Website : www.jenburkt.com

Registrar's Details : Bigshare Services Pvt Ltd
Office No S6-2, 6th Floor, Pinnacle Business Park,Next to Ahura Centre, Mahakali Caves Road,Andheri (E),Mumbai
Listing : BSE
NEWS
06Nov Jenburkt Pharmaceuticals informs about
With reference to letter No. JPL/CS/2140/2024 dated 5th November, 2024,..
28Oct Jenburkt Pharmaceuticals informs about
In continuation to letter No. JPL/CS/2126/2024 dated 23rd September, 202..
30Jul Jenburkt Pharmaceuticals informs about
Pursuant to Regulation 39(3) of the Securities and Exchange Board of Ind..
27Jul Jenburkt Pharmaceuticals informs about
With reference to letter No. JPL/CS/2110/2024 dated 26th July, 2024, Jen..
02Mar Jenburkt Pharmaceuticals informs about
In terms of Regulation 39(3) of the Securities and Exchange Board of Ind..
Financials
in Millions
QTR Sep 24 ANNUAL 24
Net Profit96.02259.76
Gross Profit 125.24 351.74
Operating Profit 132.79377.85
Net Sales 412.161419.66
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Abbott India (BSE)
 28633.50 (0.60%)
M.Cap ( in Cr)
60844.19
Divi's Lab (BSE)
 5880.45 (1.67%)
M.Cap ( in Cr)
156107.47
Innova Captab (BSE)
 1059.10 (8.12%)
M.Cap ( in Cr)
6060.69
Pfizer (BSE)
 4875.60 (1.40%)
M.Cap ( in Cr)
22304.76
Procter&Gamble Healt (BSE)
 5446.35 (0.91%)
M.Cap ( in Cr)
9040.60
Shareholding Pattern
NON-INSTITUTION 53.29%
PROMOTERS 46.71%
MUTUAL FUNDS/UTI 0%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%
Mf Holding
Scheme NameHold(%)
No Data Found
ATTENTION INVESTORS

Kalpataru Multiplier Ltd.

Kalpataru is a wishful Divine Tree and in present context a widely Trusted, Time tested and Transparent Share Broker, Mutual Fund Distributor and D.P. of this region.

Mobile Trading App
Mobile Trading IOS App
Call Us 0755-4350141/142/143, 9425008895
Mutual Funds 0755-4276725, 4276726
Email Uskmlho@kalpatarumulti.com

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalparatu Multiplier Ltd.
Designed ,Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.
SENSEX78472.48-0.39 (0.00%)
NIFTY23750.2022.55 (0.10%)
Dow Jones 43297.03390.08 (0.91%)
Nasdaq 20031.13266.25 (1.35%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI